LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

915.09 -3.91

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

894.09

Max

966.46

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

27.781

121.746

Dividendenrendite

0.32

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+1.22% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.32%

2.26%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

13B

119B

Vorheriger Eröffnungskurs

919

Vorheriger Schlusskurs

915.09

Nachrichtenstimmung

By Acuity

42%

58%

126 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Feb. 2026, 23:47 UTC

Heiße Aktien

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11. Feb. 2026, 22:59 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Grab Holdings to Buy U.S.-Based Stash Financial

11. Feb. 2026, 23:54 UTC

Ergebnisse

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11. Feb. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11. Feb. 2026, 23:49 UTC

Ergebnisse

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11. Feb. 2026, 23:45 UTC

Ergebnisse

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11. Feb. 2026, 23:42 UTC

Ergebnisse

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11. Feb. 2026, 23:41 UTC

Ergebnisse

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11. Feb. 2026, 23:40 UTC

Ergebnisse

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11. Feb. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11. Feb. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11. Feb. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11. Feb. 2026, 22:58 UTC

Ergebnisse

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11. Feb. 2026, 22:57 UTC

Ergebnisse

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11. Feb. 2026, 22:54 UTC

Ergebnisse

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11. Feb. 2026, 22:53 UTC

Ergebnisse

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:23 UTC

Ergebnisse

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11. Feb. 2026, 22:19 UTC

Ergebnisse

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11. Feb. 2026, 22:16 UTC

Ergebnisse

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

1.22% Vorteil

12-Monats-Prognose

Durchschnitt 974.09 USD  1.22%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

126 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat